Serinus Biosciences

Inscrição YC de Serinus Biosciences

Summer 2022Active

Serinus Biosciences passou pela Y Combinator no batch Summer 2022 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC
Summer 2022
Indústria
HealthcareTherapeutics
Tamanho da equipe
6
Status
Active
Lançada
2022

Fundadores

  • Adam Yaari
    Adam YaariFounder/CEO
  • Maxwell Sherman
    Maxwell ShermanFounder/CTO

O que Serinus Biosciences faz

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Inscrição YC de Serinus Biosciences, reconstruída

Inscrição Y Combinator

Serinus Biosciences, lote Summer 2022. As verdadeiras perguntas do formulário, respondidas com dados públicos.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Serinus Biosciences

Describe what your company does in 50 characters or less.

Combinations therapy by rational design

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that designs combination therapies to overcome cancer treatment resistance. Our system uses decades of system biology knowledge to model how cancer evolves escape routes to therapies, allowing us to propose molecule combinations that are more effective and safer. The output is explainable, letting researchers and clinicians understand why the selected combinations work.

Where do you live now, and where would the company be based after YC?

We live and operate in New York, NY, USA, and plan to keep the company based here after YC.

Explain your decision regarding location.

New York is a biotech and healthcare innovation hub with access to top academic partners and talent. Staying here lets us collaborate closely with our scientific advisors and prospective customers while benefiting from YC's remote-friendly approach.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Perguntas Frequentes

Esta é a inscrição real da YC de Serinus Biosciences?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Serinus Biosciences (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Serinus Biosciences se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Serinus Biosciences esteve?

Serinus Biosciences fez parte do batch Summer 2022 da Y Combinator.

Quem fundou o Serinus Biosciences?

O Serinus Biosciences foi fundado por Adam Yaari, Maxwell Sherman.

O que o Serinus Biosciences faz?

Combinations therapy by rational design

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Serinus Biosciences, e de todos os outros lotes do YC, está no YC Insights.

Mais startups YC como Serinus Biosciences